Business Daily.
.
A+ R A-

The Conversation

imageKeytruda® targets a protein on the surface of immune cells that stopped them from attacking the melanoma cells.Australis Photography/Shutterstock

Keytruda® (pembrolizumab) is the latest drug to be registered in Australia for the treatment of widespread melanoma. This is the third class of drugs that improves survival in widespread melanoma...

Page 21957 of 27002

The Conversation


Grow Your Business with Times Media

Business Daily Media